Director Pereira sells entire stake of 757,162 shares across 4 transactions for $1.9M as PROK faces $-16.5M annual loss and 53.5% stock decline from highs.
Brian JG Pereira, a director at ProKidney Corp., executed a complete liquidation of his equity position through 4 separate sales totaling 757,162 shares for $1,884,577.38 across November 12-13, 2025, reducing his holdings from 757,162 shares to 0 shares (-100.0%). The sales occurred at prices between $2.37 and $2.72 per share, against a current price of $2.41 and a 52-week high of $5.18. This exit occurs in the context of severe operational headwinds: the company posted net income of $-16,469,000.00 on minimal revenue of $217,000.00 in its latest quarter, and reported negative full-year earnings. The complete divestiture of the director's equity stake—rather than a partial or gradual reduction—coincides with the stock trading 53.5% below its 52-week peak and down 24.0% over the prior 30 days, suggesting the director has no remaining financial alignment with future company performance.